YIFENG PHARMACY CHAIN CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.3 CNY | -1.28% |
|
+1.45% | +8.14% |
| Sales 2023 * | 23B 3.17B 265B | Sales 2024 * | 28.25B 3.9B 325B | Capitalization | 43.76B 6.04B 504B |
|---|---|---|---|---|---|
| Net income 2023 * | 1.44B 198M 16.51B | Net income 2024 * | 1.79B 247M 20.63B | EV / Sales 2023 * | 1.74 x |
| Net cash position 2023 * | 3.66B 504M 42.06B | Net cash position 2024 * | 6.18B 852M 71.07B | EV / Sales 2024 * | 1.33 x |
| P/E ratio 2023 * |
30.9
x | P/E ratio 2024 * |
24.6
x | Employees | - |
| Yield 2023 * |
0.71% | Yield 2024 * |
0.9% | Free-Float | 44.89% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -1.28% | ||
| 1 week | +1.45% | ||
| Current month | +8.71% | ||
| 1 month | +10.52% | ||
| 3 months | +11.57% | ||
| 6 months | +36.42% | ||
| Current year | +8.14% |
1 week
42.33
44.80
1 month
39.0544.80
Current year
36.9045.00
1 year
30.9045.00
3 years
22.4652.50
5 years
22.1760.57
10 years
5.5060.57
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Gao
CEO | Chief Executive Officer | 55 | 01/08/01 |
Jian Qin Deng
DFI | Director of Finance/CFO | 44 | 29/19/29 |
En Bo Zhang
COO | Chief Operating Officer | 29 | 01/17/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Xu
BRD | Director/Board Member | 57 | 01/09/01 |
Min Gang Chai
BRD | Director/Board Member | 55 | 29/21/29 |
Yi Gao
CEO | Chief Executive Officer | 55 | 01/08/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.07% | 3 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 43.3 | -1.28% | 7,140,651 |
| 25/24/25 | 43.86 | -0.18% | 3,792,256 |
| 24/24/24 | 43.94 | +0.76% | 5,429,975 |
| 23/24/23 | 43.61 | +1.07% | 3,859,241 |
| 22/24/22 | 43.15 | +1.10% | 2,914,448 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Yifeng Pharmacy Chain Co Ltd is a China-based company principally engaged in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The Company mainly operates through retailing segment. The Company operates direct pharmaceutical chain stores mainly in provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The Company is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.
Sector
Drug Retailers
Calendar
29/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
43.3
CNY
Average target price
50.92
CNY
Spread / Average Target
+17.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.14% | 6.04B | |
| -32.21% | 15.27B | |
| -31.97% | 10.84B | |
| -30.42% | 6.06B | |
| -11.41% | 5.86B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
- Stock Market
- Equities
- 603939 Stock
